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Abstract
The CytoscanTM Model E-II (Cytometrics Inc., Philadel-
phia, Pa., USA) is a newly developed instrument which
functions as an intravital microscope and is small and
easily portable. Through the use of orthogonal polariza-
tion spectral (OPS) imaging, the Cytoscan Model E-II
delivers images of the microcirculation which are com-
parable to those achieved with intravital fluorescence
videomicroscopy (IFM), but without the use of fluores-
cent dyes. The purpose of this study was to validate the
Cytoscan Model E-II instrument against IFM. The experi-
ments were carried out on striated muscle in the dorsal
skinfold chamber of the awake Syrian hamster. The fol-
lowing parameters were measured in identical regions
of interest in the same animal under baseline conditions
and 0.5 and 2 h after a 4-hour period of pressure-induced
ischemia: arteriolar diameter, venular diameter and ve-
nular red blood cell velocity. Bland-Altman plots showed
good agreement between the two techniques for venular
red blood cell velocity. As expected, arteriolar and venu-
lar diameters as measured by the Cytoscan were on
average 5 Ìm smaller than the values from IFM, since the
Cytoscan measures the red blood cell column width and
IFM measures luminal diameter. Thus, OPS imaging can
be used to make valid measurements of microvascular
diameter and red blood cell velocity in tissues.
Copyright © 2000 S. Karger AG, Basel
Introduction
Intravital microscopy has been used for many years to
make quantitative observations of the microcirculation.
Early experiments were limited to very thin tissues such
as the bat wing [1] or tadpole tail [2], in order to ensure
that enough light penetrated the tissue by transillumina-
tion so that measurements could be made.
More recently, the use of fluorescent dyes with epiillu-
mination has become widespread because it offers several
advantages. The image contrast is greatly improved and it
is also possible to selectively mark a specific type of cell,
making their identification easier and more quantitative.
Because of the high image contrast achieved when using
fluorochromes, intravital microscopy could be performed
on more solid tissues such as the liver and brain.
However, the use of fluorescent dyes also has several
disadvantages. The binding of the dye to the cell could
have undesired side effects such as altering the cell func-
tion or even killing the cell through some toxicity reaction.
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Fig. 1. The Cytoscan Model E-II instrument. Note the small size and
portability of the instrument compared to standard intravital micro-
scopes.
The presence of a fluorochrome and the high light intensi-
ties used in epiillumination can themselves lead to so-
called phototoxic effects [3–5]. Phototoxic effects result
from the high energy levels present in the tissue and can
lead to the production of reactive oxygen species. Their
release can cause leukocyte activation, platelet aggrega-
tion, vasoconstriction and a loss of capillary perfusion. In
this respect, the measurement itself can alter the very
parameters that the researcher is trying to measure.
In addition, studies of the microcirculation are re-
stricted almost exclusively to animal models because of
the necessity of the use of fluorescent dyes. They are in
general themselves toxic and there is only a single dye
which has been approved for use in humans. Because of
the risk of phototoxic effects, it is used very sparingly.
Measurements of the human microcirculation can be
made through the capillary nailfold bed without the use of
fluorescent dyes, but this procedure has only limited
application and has yet to find widespread clinical accep-
tance [6]. Since the microcirculation plays a critical role in
many disease states, such as diabetes and hypertension, a
knowledge of its structure and function in humans is of
great importance [6]. Thus, the ability to study the micro-
circulation of solid organs without the use of fluorescent
dyes would represent important progress for clinical med-
icine.
The CytoscanTM Model E-II (Cytometrics Inc., Phila-
delphia, Pa., USA; Cytoscan is a trademark of Cytome-
trics Inc.), shown in figure 1, is a newly developed, small,
hand-held device. Because of its small size, it can easily be
transported and used in a variety of situations which
would be impossible to access with a large, standard
intravital microscope. The Cytoscan Model E-II makes
use of orthogonal polarization spectral (OPS) imaging to
obtain images in reflected light using hemoglobin absor-
bance, which can be analyzed quantitatively off-line [7].
Slaaf et al. [8] have shown that the use of two polarizers
could improve image contrast during epiillumination
with white light in a standard microscope. With OPS
imaging, high-contrast ‘transillumination-like’ images can
be obtained not only from thin tissues, but from the sur-
face of large solid organs as well. Given the problems asso-
ciated with fluorescent dyes, as discussed above, such a
device could be a valuable new tool for studying the
microcirculation, particularly in humans. Since the mi-
crocirculation plays a central role in many cardiovascular
diseases, there is a need for such a device [6]. Prior to
performing studies in humans, it is first necessary to vali-
date the device against a standard technique used to
observe the microcirculation.
Two important microvascular parameters are vessel
diameter and red blood cell velocity. Since OPS imaging
uses hemoglobin absorbance to achieve contrast, the di-
ameter which it measures will be that of the red cell col-
umn. In intravital fluorescence microscopy (IFM), a fluo-
rescent dye is used to achieve contrast, so the diameter
measured using this technique will be the luminal diame-
ter, which will be larger than the diameter of the red cell
column. The validation of the new method by comparison
to an established one is further complicated here by the
dynamics of the microcirculation. It is known that both
vessel diameter and red blood cell velocity are dynamic
parameters which change over time. Since the vessels can-
not be imaged with the two techniques simultaneously,
the measurements which are made on the exact same ves-
sel are separated in time. This means that the true values
to be measured are actually different for the two tech-
niques. Therefore, a large amount of scatter is to be
expected within the data when directly comparing the two
techniques. Despite these complications, validation of
OPS imaging is still necessary to show that it can be used
to make quantitative measurements of microvascular pa-
rameters.
Therefore, the aim of this study was to validate the use
of the Cytoscan Model E-II for making microvascular
measurements against standard IFM under normal condi-
tions and in a disease state, in this case after ischemia/
reperfusion injury.
CytoscanTM Model E-II: A New Microscope J Vasc Res 2000;37:469–476 471
Materials and Methods
The dorsal skinfold chamber in 10 awake male Syrian golden
hamsters was the model used to make the comparative microvascular
measurements. It is a highly standardized and controlled model
which has been used extensively to study ischemia/reperfusion injury
[9–11]. The animals were purchased from Charles River Wiga (Sulz-
bach, Germany); they were 6- to 8-week-old and had a body weight
of 60–80 g. They were kept at 21°C in a normal cycle of 12 h of light
and 12 h of darkness, and fed laboratory chow (120 mg of vitamin E,
18,000 IU of vitamin A per kilogram) ad libitum (ssniff, Spezialdiä-
ten GmbH, Soest, Germany).
Surgical Procedure
The chambers and the surgical implantation procedure used in
this study are based on those presented by Harris et al. [11] and
Endrich et al. [12], with only a few minor modifications. Briefly, the
hamsters were anesthetized by intraperitoneal injection of ketamine/
xylazine (100 mg/kg body weight; Ketavet, 50 mg/ml; Parke-Davis,
Berlin, Germany)/(10 mg/kg body weight; Rompun, 2%; Bayer, Le-
verkusen, Germany). The hair was removed from the back of the
animals and an extended double layer of skin on the dorsal skinfold
was sandwiched between two symmetrical titanium frames. From
one of the skin layers, a circular area 15 mm in diameter was com-
pletely removed and the remaining layers (consisting of the epider-
mis, subcutaneous tissue and a thin striated skin muscle) were cov-
ered with a glass coverslip incorporated into one of the frames.
After a recovery period of 24–48 h, a fine polyethylene catheter
was inserted into the jugular vein under the same anesthesia protocol
for the application of fluorescent dye. The catheter was passed subcu-
taneously into the dorsal side of the neck and secured to the titanium
frames. The animals tolerated the dorsal skinfold chambers well and
no effects on their eating and sleeping habits were observed. The ani-
mals were allowed another recovery period of 24–48 h before experi-
mental observations were made, to eliminate the effects of anesthesia
and surgical trauma on the microvasculature.
Intravital Microscopy
The setup and microscope used to make the IFM measurements
have been presented in detail by Harris et al. [13]. The awake animals
were immobilized in a plexiglass tube and the chamber was attached
to a microscope stage which is computer controlled to allow for
repeated scanning of identical segments of microvessels. A 10-fold
water immersion objective (Zeiss Axiotech vario 100 HD micro-
scope, Acroplan 10!/0.5 W, Zeiss, Oberkochen, Germany; pixel
resolution 1.5 Ìm) was used to observe the skin microvasculature
under epiillumination. The fluorescent images were captured using a
charge-coupled device video camera (FK 6990 IQ-S, camera size
2 cm, Piper, Schwerte, Germany). The images were recorded onto
S-VHS video tape (video recorder SVO-9500 MDP, Sony, Köln,
Germany) for later off-line analysis. For transillumination, a 15-volt,
150-watt halogen lamp (Schott 1500 electronic, Schott, Mainz, Ger-
many) was used in combination with a green filter (wavelength 546
B 12 nm; Zeiss) to enhance contrast. Epiillumination was achieved
using a 12-volt, 100-watt halogen lamp (Zeiss). The halogen lamp was
used in conjunction with the Zeiss filter set 09 (BP 450–490, FT 510,
LP 520) for measurements involving fluorescein isothiocyanate-
labeled dextran (FITC-dextran).
To take advantage of the computer-controlled functions of the
X-Y plate, the Cytoscan Model E-II was attached to the shaft of the
microscope using a specially designed C clamp. The stage was modi-
fied so that there were two different pairs of holes through which the
stage could be attached to the motorized plate. One pair of holes
aligned the chamber under the fluorescence microscope, the other set
aligned the chamber under the Cytoscan Model E-II. By simply mov-
ing the stage from one pair of holes to the other, the identical region
of interest could be observed with the two systems. The Cytoscan
Model E-II was equipped with a 10! lens system with a numerical
aperture of 0.26, yielding a pixel resolution of 1 Ìm. The Cytoscan
Model E-II images were captured using a mini-CCD camera (Costar
CV-M536 CCIR, camera size 0.5 inches, JAI Corporation, Japan)
and recorded on S-VHS video tape using the same video recorder as
the IFM system. The light source for the Cytoscan Model E-II is a
variable halogen bulb with a maximum current of 0.73 A and a color
temperature of 3,250 K (Welch Allyn, Skaneateles Falls, N.Y., USA).
In order to easily visualize erythrocytes, the polarized light is passed
through a green filter to illuminate the tissue with light at a wave-
length of 550 nm.
For the measurement of arteriolar diameter, two regions of inter-
est containing terminal arterioles ranging in diameter from 20 to
85 Ìm were selected. For the measurement of venular diameter and
venular erythrocyte velocity, seven regions of interest within the
striated muscle in the chamber which contained one or more small
venules ranging in diameter from 15 to 65 Ìm were selected. FITC-
dextran (0.05 ml, 3%, Mr = 150,000; Sigma, St. Louis, Mo., USA)
was used for contrast enhancement of the microcirculation for the
IFM measurements.
Microcirculation Measurements
Under transillumination, the two arteriolar regions and the seven
venular regions of interest were randomly selected and their position
stored in the computer. Using the computer-controlled plate and the
specially designed stage, these positions can be relocated at any time
for observations either by IFM or the Cytoscan Model E-II. The base-
line measurements were then made with both systems in a random-
ized order, so that in half of the animals, the IFM measurements were
made first and in the other half, the Cytoscan measurements were
made first. Shortly prior to the fluorescence microscopy measure-
ments, an intravenous injection of FITC-dextran at the aforemen-
tioned dose was given. For the fluorescence measurements, each of
the seven venular areas and two arteriolar regions were observed for
approximately 20 s. Throughout the observations, special care was
taken to minimize the amount of epiillumination on the tissue. The
total exposure time under epiillumination was less than10 min per
observation period. For the Cytoscan Model E-II measurements,
each of the observation areas was videotaped for approximately
30 s.
Ischemia Induction
To validate the Cytoscan Model E-II measurements in a complex
pathological situation, the chamber tissue was subjected to a 4-hour
period of pressure-induced ischemia following the recording of the
baseline conditions [14]. The ischemia was induced by gently press-
ing the skin tissue against the cover slip from the backside with a
silicone pad by slowly tightening an adjustable screw under micro-
scopic control until the blood vessels emptied and the tissue ap-
peared white. Following the 4-hour ischemia, the screw was released
and the silicone pad was removed. The observation procedure was
repeated after 0.5 and 2 h of reperfusion. In five animals, the fluores-
cence microscopy measurements were made first, and in the other
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Fig. 2. Typical images from standard fluo-
rescence microscopy (A) and the Cytoscan
Model E-II (C) under baseline conditions.
Pictures of the same venule following a 4-
hour period of pressure-induced ischemia
and 0.5 h of reperfusion from standard fluo-
rescence microscopy (B) and the Cytoscan
Model E-II (D) are also shown.
five animals, the Cytoscan Model E-II measurements were made
first, to assure that no bias was introduced as a result of the measure-
ments being made consecutively and not simultaneously. At the con-
clusion of the study, the animals were sacrificed with an overdose of
pentobarbital sodium (Narcoren®, Rhone Merieux GmbH, Laup-
heim, Germany).
Microcirculatory Analysis
The images from both systems were analyzed during playback
using a computer-assisted microcirculation analysis system (Cap-
Image; Dr. Zeintl, Heidelberg, Germany) [15]. The system was cali-
brated for the two devices according to the manufacturer’s instruc-
tions. The vessel diameter and midstream red cell velocity were
determined from both the FITC images and the Cytoscan Model E-II
images. The vessel diameter was measured with Cap-Image using the
manual mode, where the user determines the diameter with two
mouse clicks on the outer edges of the contrast-producing structure.
For the IFM measurements, the diameter was measured from the
two edges of the plasma fluorescence (inner vessel wall). For the
Cytoscan measurements, the diameter was measured from the two
edges of the observed red cell column (the inner vessel wall is not
clearly depicted).
Velocity was determined using the line shift diagram option in
Cap-Image. For this procedure, a line is drawn down the middle of
the vessel. The pixels under this line are then stored for 10 s and
placed vertically next to each other. Particles traveling along the line
produce stripes in the vertical pixel presentation. From the length
and slope of these stripes, the velocity of the particles can be calcu-
lated.
Statistical Analysis
The mean values from the average value of each experiment for
each parameter were compared using a Student’s t test. The data
were analyzed using a linear regression and a Spearman rank order
correlation (Sigma Stat 2.0, Jandel Scientific, Erkrath, Germany).
The data were further analyzed using Bland-Altman plots as the best
statistical method for assessing agreement between two different
methods where neither method yields the true value [16, 17]. The
data are plotted as a scatter plot of the mean value of the two methods
versus the difference between the two methods.
Results
Typical images from fluorescence microscopy and the
Cytoscan Model E-II under baseline conditions and after
the ischemic insult are shown in figure 2. A total of 10
experiments in 10 different animals were carried out for
this study. In each experiment, nine venules and two arte-
rioles were examined. Table 1 shows the mean values and
standard deviations for the two different techniques for
the three different time points. There were no significant
differences between the two techniques for any of the
parameters.
The regression analyses of the data for the arteriolar
diameter, venular diameter and venular red blood cell
velocity were performed and the R2 values were 0.63, 0.68
and 0.56, respectively. The Spearman rank order correla-
tion for all three parameters was also significant, with cor-
relation coefficients of 0.793, 0.838 and 0.745, respective-
ly, indicating that the two methods yield comparable
results.
Arteriolar diameter, Ìm
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Fig. 3. A Bland-Altman plot of the arteriolar diameter measurements
for all three time points (n = 60). The solid line represents the mean
difference, which is 5.0 Ìm, and the standard deviation of the differ-
ence is 11.0 Ìm. The dashed lines represent B2 standard deviations
of the mean difference. The dotted line represents a linear fit of the
plotted points. The two methods show good agreement despite the
fact that the Cytoscan Model E-II measurements are approximately
5 Ìm less than the IFM measurements.
Fig. 4. A Bland-Altman plot of the venular diameter measurements
for all three time points (n = 270). The solid line represents the mean
difference, which is 4.2 Ìm, and the standard deviation of the differ-
ence is 8.7 Ìm. The dashed lines represent B2 standard deviations of
the mean difference (the 95% confidence interval). The dotted line
represents a linear fit of the plotted points. The two methods show
good agreement despite the fact that the Cytoscan Model E-II mea-
surements are approximately 4 Ìm less than the IFM measure-
ments.










44.9B15.2 40.0B15.1 52.9B12.7 49.3B12.3 51.8B17.0 50.0B12.5
Venular diameter, Ìm 38.4B4.9 33.6B6.3 49.7B5.3 42.5B5.9 45.7B6.5 43.3B6.2
Venular RBC velocity, mm/s 0.62B0.14 0.62B0.13 0.64B0.29 0.59B0.26 0.66B0.22 0.61B0.24
RBC = Red blood cell.
The Bland-Altman plots for venular diameter and
venular red blood cell velocity showed a strong similarity
at all three time points. The mean difference and the
linear fit to the points, as well as the 95% confidence inter-
vals, were all very similar. Therefore, the combination of
the data into a summary plot is justified. In the case of
the arteriolar diameter, the similarities were not as strong,
but this is due to the much lower number of measure-
ments made, and thus, the combination of the data into
a summary plot is also justified. The data from all three
time points were therefore combined and the summary
Bland-Altman plots for arteriolar diameter, venular di-
ameter and venular red blood cell velocity are shown in fig-
ures 3–5, respectively. The bias and precision for the pa-
rameters were 5.0 B 11.0 Ìm, 4.2 B 8.7 Ìm and 0.03 B
0.25 mm/s.
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Fig. 5. A Bland-Altman plot of the venular red blood cell (RBC)
velocity measurements for all three time points (n = 270). The solid
line represents the mean difference, which is only 0.03 mm/s, and the
standard deviation of the difference is 0.25 mm/s. The dashed lines
represent B2 standard deviations of the mean difference (the 95%
confidence interval). The dotted line represents a linear fit of the
plotted points. The two methods show good agreement.
Discussion
The data demonstrate that the Cytoscan Model E-II
can be used to measure the three microvascular parame-
ters studied under both physiological and pathophysiolog-
ical conditions. From table 1, it can easily be seen that the
mean values and standard deviations for all three parame-
ters with the two different techniques are comparable at
all time points. The regression analysis also showed a sig-
nificant correlation between the two techniques for all
three parameters. From the Bland-Altman analysis, it is
also apparent that there is good agreement between the
two techniques in respect to venular red blood cell veloci-
ty. For the diameter measurements, the Cytoscan Model
E-II values are less than those from fluorescence micros-
copy, but the relative changes measured by the two tech-
niques are comparable. The changes observed here were
what was expected and are comparable to those observed
in previous studies [11, 14].
The regression analysis and Spearman rank order cor-
relation showed a significant correlation between the two
techniques. For all three parameters, the p value was less
than 0.05.
From the Bland-Altman plots, a true comparison be-
tween the two systems can be easily made. For all three
parameters, the Bland-Altman plots showed good agree-
ment between the two techniques at all three time points.
This is an indication that valid microvascular measure-
ments can be made under both physiological and patho-
physiological conditions. Because there were no differ-
ences in the plots for the three separate time points, the
data for each parameter were combined into one single
plot.
The measurements of venular red blood cell velocity
show good agreement between the two techniques, as all
four criteria suggested by Bland and Altman are met:
mean difference or bias of zero, slope of the linear regres-
sion of zero, 95% of all of the values within B 2Û, and a
95% confidence interval of an acceptable range [17]. The
solid line represents the mean difference or the estimated
bias [16]. Since it is almost zero, this indicates that there is
no systematic difference between the two techniques. The
dotted line represents a linear fit of the data points and it
has a slope of almost zero, indicating that the variance
between the measurements is constant throughout the
velocity range studied, according to the Bland-Altman
analysis. Hence, larger values do not tend to have statisti-
cally larger differences, although from the figure this does
not appear to be the case. Since the variation is normally
distributed, the mean difference remains constant. Less
than 5% of the values lie outside of the 95% confidence
interval. Furthermore, this interval is of an acceptable
range. It is known that in this model using Cap-Image for
the measurement of velocity, the standard deviation of
repeated measurements of the same vessel over time is
approximately 0.2 mm/s. This value was obtained by re-
analyzing data from control animals in previous experi-
ments. This seemingly large variability stems from the
dynamic nature of the measurement. In the microcircula-
tion, there is a large degree of heterogeneity in the flow
through the small vessels, meaning that it is constantly
changing even if the macrohemodynamic parameters re-
main constant. Thus, since the standard deviation of the
difference between the two techniques (0.25 mm/s) is
comparable with that of the standard deviation of the
measurement with only a single method (0.2 mm/s), this
range of the 95% confidence interval is acceptable. Be-
cause all four criteria set by Bland and Altman are met, it
is an indication that the two methods are in agreement for
the measurement of venular red blood cell velocity.
In a study recently published by De Vriese et al. [18],
the authors also looked at the variability in blood flow
measurements in arterioles using the line shift diagram
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method in Cap-Image. Using a high-speed camera, they
measured velocities up to 40 mm/s and found that
repeated measurements of the same vessel differed by up
to 25%, which would correspond to a standard deviation
of 5–10 mm/s. This was found to be an acceptable range
of variation. In the current study, a similar percentage of
variation was also observed. In this context, the variabili-
ty found in the current study is also acceptable.
In the measurement of microvascular diameter, both
arteriolar and venular, the analysis is more complicated,
due to the fact that the mean difference or bias is not zero.
With the Cytoscan Model E-II, the diameter values ob-
tained were approximately 5 Ìm less than those from fluo-
rescence microscopy. This result is actually to be ex-
pected, given the nature of the measurement with fluores-
cence microscopy. Gretz and Duling [19] showed that
interfacial scattering causes an overestimation of capillary
diameter by as much as 10%. The interfacial scattering
occurs as a result of the refractive index mismatch be-
tween the tissue and the plasma, which leads to the out-
of-focus halo of light making the object appear larger due
to the acceptance angle of the objective. They reported
that diameters measured using fluorescence microscopy
are overestimated by as much as 0.8 Ìm. Hence, scatter-
ing could account for approximately 1 Ìm of the bias
observed in the current study.
In addition, the two methods are actually measuring
two different ‘diameters’. For the IFM measurements,
FITC-dextran is used as a plasma marker. The diameter
of the vessel is then measured as the distance within the
vessel between the two edges of the fluorescence compart-
ment, which is the distance between two endothelial cells
on opposing sides of the vessel. With the Cytoscan Model
E-II, the diameter is measured as the width of the red
blood cell column present in the vessel. It is well known
that between the red blood cells and the endothelial cell
there is a layer of plasma up to 2 Ìm thick [20]. In fact,
these two different diameters have also been discussed by
Michoud et al. [21] in a study in which they examined two
different algorithms for the automatic measurement of
vascular diameter. The bias of 4–5 Ìm observed in this
study can be explained by the two different diameters
measured and the additional overestimation of the diam-
eter due to fluorescent interfacial scattering. Therefore, it
is to be expected that the Cytoscan Model E-II diameter
values should be less than those obtained by fluorescence
measurements, hence the systematic difference observed
in both the arteriolar and venular diameter measure-
ments.
Since the slope of the linear fit to the data is nearly zero
in both plots, this is an indication that the bias is constant
over the entire range of values studied. Thus, if the
desired diameter was the distance between two opposing
endothelial cells, it would be possible to correct the red
cell column diameter measured using the Cytoscan to give
this value. However, when extreme alterations in the local
hematocrit or sludging occur, this correction factor could
change.
An overwhelming majority of the values we recorded
are situated within the 95% confidence interval. At first
glance however, it would appear that this interval is unac-
ceptably large due to the scatter of the data. This scatter is
actually to be expected, since the vessels are not rigid
tubes and are thus affected by the dynamics of blood flow.
Since the measurements with the two techniques were
separated by approximately 15 min, changes in vessel
diameter during that time will occur. In studies in our lab-
oratory using the same model, we found variations in the
diameter of a single vessel over time of up to 8 Ìm, and
there was a standard deviation of 4 Ìm using a single
method. Intaglietta and Hammersen [22] have also re-
ported that due to vasomotion, the venular vessel diame-
ter changes on average by 10% and the diameter of small
arterioles can vary by up to 100%. This greater variation
in the true vessel diameter over time is reflected in our
data by the larger 95% confidence interval calculated for
the arterial diameter data. An additional amount of scat-
ter is certainly also introduced by the fact that the two
methods are measuring different diameters. Thus, while
the scatter observed in this study for the measurement of
diameter appears to be large, it is actually to be expected
and therefore of an acceptable range. Since the four crite-
ria of Bland and Altman are satisfied, it can be said that
there is acceptable agreement between the two techniques
for the measurement of vessel diameter. The small size
and portability of the Cytoscan Model E-II is also an
improvement over standard microscopes. It can easily be
placed on a small cart and transported. With the hand-
held probe, it is also very easy to access any exposed tis-
sue.
Conclusions
With the unique technology of the Cytoscan Model E-
II, transillumination-like images of the microcirculation
can be obtained using epiillumination. From these
images, it is possible to make accurate off-line quantita-
tive measurements of vessel diameter and venular red
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blood cell velocity. Leukocytes can occasionally be identi-
fied, but not to an extent which allows quantitative mea-
surements. Further improvements to the system should
make the measurement of leukocytes possible. The Cyto-
scan Model E-II should prove to be a valuable new tool for
the study of the human microcirculation, especially in sol-
id organs where measurements without fluorescent dyes
are as yet not possible. Furthermore, the ability to make
measurements in the microcirculation without fluores-
cent dyes opens up the possibility for broad clinical appli-
cations where the use of fluorescent dyes in patients is not
feasible. The small size and portability of the Cytoscan
also make it possible to observe the microcirculation in
situations where a standard microscope could not be
used.
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